Cascadia’s Post

🌟 We are thrilled to announce that we have collaborated with Global Parents for Eczema Research on a meaningful research project that has been published in the Australasian Journal of Dermatology! 📚 The study delves into the impact of the current care model on disease management and quality of life for patients with atopic dermatitis (eczema) in Australia. Here are some key findings from our research: ➡️ Patients are experiencing a significant burden of disease and report unsatisfactory quality of life, with poor long-term control and low treatment satisfaction. ➡️ Many patients are also facing financial challenges, with changes in spending and saving patterns to cover medical expenses. This research sheds light on the challenges faced by individuals managing eczema in Australia and emphasizes the importance of improving the current care model to enhance patient outcomes. 🌿 If you're interested in learning more about our findings, check out the full article: https://hubs.ly/Q02xR-SX0 This study was also sited in the Eczema Support Australia groundbreaking report: 'The Burden of Eczema - A Call for a National Strategy' https://hubs.ly/Q02xRFQJ0 #Research #AtopicDermatitis #PatientCare #QualityOfLife #Dermatology #Australia #Healthcare #Innovation

🚀 New Insights in Topical Drug Delivery! 📥 Download the PDF: https://lnkd.in/dEi7YurF The topical drug delivery market is rapidly evolving, bringing new innovations in skin, eye, and mucous membrane treatments. With a growing focus on non-invasive methods, this market is unlocking improved patient outcomes and more targeted therapies. 💡 Did you know? The topical drug delivery market was valued at $207.4 billion in 2022 and is projected to skyrocket to $317.8 billion by 2027, with an impressive CAGR of 8.9%! 📈 This growth reflects the increasing demand for efficient and localized treatments in dermatology, ophthalmology, and pain management. #TopicalDrugDelivery #PharmaInnovation #DrugDelivery #Healthcare #MarketGrowth #Dermatology #Ophthalmology #CAGR #PharmaIndustry

📌 Today we participate in the #IXCongresoDePsoriasis organised by the Academia Española de Dermatología y Venereología (AEDV), where we shared our commitment to #patient care in #dermatology, advancing unmet needs and presenting our latest research and innovations. ➡️ #Psoriasis is a widely prevalent chronic systemic immune disease that affects an estimated 100 million people worldwide. 👤 Although #psoriasis patients share similar symptoms, their experiences are unique. There is a world of difference in the psoriatic community and many may experience stigma due to the impact of psoriasis on their daily lives. 🤝 It is essential that specialist and patient jointly assess which is the most appropriate treatment according to their personal circumstances, needs and preferences. 🔬 At Bristol Myers Squibb we are committed to improving patients' lives by providing treatments at the forefront of scientific innovation. #CongresoPsoriasis2024 #BMSIberia #BMSPortugal #BMSEspaña #BMSCommunity #BMSTransformingLives #WorkingTogetherforPatients #BMSTransformingPatientsLive  

🚀 Announcing the Deployment of ES/IODE New Version: 3.4.9 🎉 We are excited to inform you that ES/IODE, the leading online scientific research platform, has released version 3.4.9, now available as of August 20, 2024! This update brings significant enhancements to improve your research experience. What's New in This Version: 1️⃣ Science Image Feature: We've optimized the layout by centering the image area and seamlessly integrating the descriptive text within the image itself, offering better readability and a more polished presentation. 2️⃣ Scientific Review Feature: We've expanded our daily study selections with a new category focusing on Respiratory Medicine, Immuno-Allergology, and Dermatology. This addition provides access to the latest and most relevant studies in these rapidly evolving fields. We invite you to explore these new features today and continue leveraging the wealth of resources available on ES/IODE. For any questions or assistance, our support team is here to help. Thank you for your continued trust, and happy researching! 🧬🔬 ES/IODE - Innovating for Science.

We at Phreesia applaud the Centers for Medicare & Medicaid Services' commitment to elevating the patient voice in healthcare: CMS released the proposed Physician Fee Schedule yesterday, and the Gains in Patient Activation Measure (PAM) Scores at 12 Months performance measure is proposed in the following new MIPS Value Pathways (MVPs) for 2025 – Ophthalmology, Dermatology , Gastroenterology, Urology, and Pulmonology. PAM was already included in 2024 in 18 MIPS specialty sets and 5 MVPS. It is a privilege to support care teams in helping every patient learn to self-manage their health, and attain the best possible outcomes. The proposed rule is here: https://lnkd.in/dHajVFYW

What is the chest physician?I know that Pulmotory as a department of Cardiologist !! Physician means= ENT+ Ophthalmology+ Dental+ Dermatology+ Gynecology+ Endocrinology+ Cardiologist+ Child specialist+Oncology+Neurology+ Brain & Strain+ Psychology+ Metal+ Orthopaedic+Urology etc)

One of the challenges in AI models is insufficient data on under represented groups or conditions. The main approach to addressing this challenge is to collect a more complete and representative data. This paper in Nature Mediicne suggests a complementary approach. The authors used #GenerativeAI to create synthetic data. They then complemented real samples with synthetic ones. This approach improved the robustness of models in medical tasks in three domains (pathology, dermatology and radiology). It increased fairness by improving the accuracy of clinical diagnosis within underrepresented groups, especially out of distribution. The authors appropriately caution that this strategy should be seen as a helpful additional strategy for improving fairness and safety in #HealthAI but not as a replacement for efforts to maximise representativeness in real data. Paper attached 👇

🌟 Seeking Collaboration with Dermatologist with Research Experience- writing meta- ananlysis or systematic review 🌟 Hello LinkedIn Community! I hope this post finds you all well. I am excited to announce that our research team is currently seeking a collaborative partnership with a skilled Dermatologist who has a background in research. This collaboration aims to advance our understanding of Biologics and skin cancer. If you are a Dermatologist passionate about research and innovation in dermatology, we would love to connect with you! Our team is dedicated to conducting meaningful studies that have a real impact on patient care and outcomes. Whether you have experience in clinical trials, epidemiological studies, or laboratory-based research, we are eager to explore how we can work together. Benefits of collaborating with us: 🔬 Access to our state-of-the-art research facilities and resources 📊 Opportunity to contribute to cutting-edge research in [biologics in dermatology] 💡 Collaborative environment with a diverse team of researchers and experts 📈 Potential for publications in renowned journals and presentations at conferences #Dermatology #ResearchCollaboration #Innovation #Healthcare #Dermatologist #ResearchOpportunity

🔍 Addressing the Dermatology Staffing Challenge: As the demand for dermatologists surges amidst a widening physician shortage, organizations must proactively manage their staffing needs. By 2034, the AAMC predicts a shortfall of up to 78,000 specialists, including dermatologists. 👵♂️ Catering to Growing Patient Demands: Seniors aged 65+ account for 37% of diagnostic tests and procedures, with their population set to reach 83.7 million by 2050. This demographic shift underscores the pressing need for dermatological expertise. 🩺 Critical Insight: Did you know that skin cancer is the most diagnosed form of cancer in the U.S.? Annually, 5.4 million cases of non-melanoma skin cancer are detected, surpassing combined cases of breast, prostate, lung, and colon cancer. 💼 Our Solution: At AMN Healthcare, our Physician Solutions team specializes in connecting healthcare facilities with top-tier dermatology professionals. We ensure that your dermatology department is well-equipped to meet the escalating needs of your patients. Don't Compromise on Patient Care: Partner with us today to overcome staffing challenges and maintain the quality of care your patients deserve. Let me know if you want a copy of our 2024 Dermatology Supply, Demand, Compensation, and Recruiting Trends White Paper. #PhysicianRecruitment #Healthcare #PhysicianShortage #PatientCare #TalentAcquisition #AMNHealthcare #Dermatology

Spherix Global Insights is thrilled to announce we are teaming up with Dermatology Times, a leading news resource at the forefront of dermatological practice, regulatory updates, practice management, and new product insights!   Together, we'll be delivering insightful publications in the evolving field of dermatology.   Stay tuned for upcoming Spherix publications and explore more here: https://lnkd.in/e_HWECMM   #DermatologyTimes #Dermatology #News